Inloggen
E-mail
Wachtwoord
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. Nederland
  4. Euronext Amsterdam
  5. Galapagos NV
  6. Nieuws
  7. Andere talen
    GLPG   BE0003818359

GALAPAGOS NV

(GLPG)
Real-time koersen. Real Time Euronext Amsterdam - 23/07 17:35:25
50.86 EUR   -0.84%
15/07Resultaten studies Galapagos niet voldoende
AM
15/07KBC Securities verlaagt koersdoel Galapagos
AM
14/07Positieve resultaten Galapagos studie bij psoriasispatiënten
AM
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Nieuws in andere talen op GALAPAGOS NV
15/07Galapagos ADRs Down After Study Data
15/07SECTOR UPDATE : Health Care Stocks Flat To Lower Pre-Bell Thursday
15/07UPDATE : Galapagos Reports Results From Phase 1b Psoriasis Study -- Shares Slump..
15/07GALAPAGOS NV : des résultats cliniques décevants
15/07GALAPAGOS : N.V., - Galapagos reports positive topline results with selective TY..
15/07GALAPAGOS : N.V., - Galapagos demonstrates early clinical activity with SIK2/3 i..
15/07GALAPAGOS : données de phase Ib positives en psoriasis
15/07GALAPAGOS : Drug Shown Safe In Three Clinical Studies
15/07GALAPAGOS' : Psoriasis Drug Shown Safe, Well-Tolerated in Early-Stage Study
14/07GALAPAGOS : demonstrates early clinical activity with SIK2/3 inhibition in infla..
14/07GALAPAGOS : reports positive topline results with selective TYK2 inhibitor GLPG3..
14/07GALAPAGOS : GLPG3667 Shows Positive Results in Psoriasis Patients, Reports Topli..
14/07GALAPAGOS : demonstrates early clinical activity with SIK2/3 inhibition in infla..
14/07GALAPAGOS : reports positive topline results with selective TYK2 inhibitor GLPG3..
14/07Galapagos NV Demonstrates Early Clinical Activity with SIK2/3 Inhibition in I..
14/07Galapagos NV Reports Positive Topline Results with Selective TYK2 Inhibitor G..
12/07GALAPAGOS : Bowel Disease Drug Shows Effect In Post-Hoc Analyses Of Late-Stage S..
10/07GALAPAGOS : announces new data supporting rapid symptom improvement and sustaine..
10/07Galapagos Announces New Data Supporting Rapid Symptom Improvement and Sustain..
23/06GALAPAGOS : announces departure of CSO Piet Wigerinck later this year (Form 6-K)
23/06GALAPAGOS : Chief Scientific Officer To Step Down
22/06GALAPAGOS : Chief Scientific Officer to Leave Company Later This Year
22/06Galapagos Announces Departure of CSO Piet Wigerinck
21/06GALAPAGOS NV(ENXTAM : GLPG) dropped from S&P Global 1200
21/06GALAPAGOS NV(ENXTAM : GLPG) dropped from S&P International 700
21/06GALAPAGOS NV(ENXTAM : GLPG) dropped from S&P EUROPE 350 - Pharmaceuticals, Biote..
21/06GALAPAGOS NV(ENXTAM : GLPG) dropped from S&P EUROPE 350 - Health Care
21/06GALAPAGOS NV(ENXTAM : GLPG) dropped from S&P EUROPE 350
08/06GALAPAGOS : increases share capital through subscription right exercises (Form 6..
07/06Galapagos increases share capital through subscription right exercises
04/06GALAPAGOS : SELECTION study on filgotinib in ulcerative colitis published in The..
04/06GALAPAGOS : Anti-inflammatory Drug Jyseleca Sustains Efficacy in Maintenance Stu..
04/06Galapagos NV Announces That Primary and Secondary Endpoint Results from the P..
28/05GALAPAGOS : to present data on rheumatoid arthritis at the upcoming European Lea..
27/05Galapagos NV to Present Data on Rheumatoid Arthritis At the Upcoming European..
19/05GALAPAGOS : announces first patient enrolled in FILOSOPHY study to advance under..
19/05GALAPAGOS : Enrolls First Patient in Post-Approval Study of Arthritis Drug
18/05GALAPAGOS : Launches Phase 4 Study of Filgotinib Rheumatoid Arthritis Medication..
18/05Galapagos Announces First Patient Enrolled in FILOSOPHY Study to Advance Unde..
18/05Galapagos announces first patient enrolled in FILOSOPHY study to advance unde..
12/05MSCI streicht Hochtief-Aktie aus Deutschland-Index
11/05GALAPAGOS : refocuses pipeline and rightsizes operations (Form 6-K)
10/05GALAPAGOS NV : les ambitions de croissance externe n'enthousiasment pas le march..
10/05AVIS D'ANALYSTES DU JOUR† : Société Générale, ArcelorMittal, Adidas, Arkema, Gal..
04/05GALAPAGOS : Transparency notification received from The Capital Group
03/05GALAPAGOS : creates new subscription right plans
28/04GALAPAGOS : Written questions and answers
23/04Gilead Sciences Submits New Drug Application in Japan for Filgotinib for the ..
23/04GALAPAGOS : Says Japanese Partner Files New Drug Application for Additional Indi..
23/04e-Therapeutics Expects to Receive Payments From Galapagos
20/04AVIS D'ANALYSTES DU JOUR† : BMW, Volkswagen, AstraZeneca, Sopra, Ipsen, Grifols,..
09/04GALAPAGOS : Gilead Extends Lock-Up Period for Galapagos Shareholding
08/04GALAPAGOS : Extension of lock-up period in Gilead-Galapagos collaboration agreem..
26/03GALAPAGOS NV : - Publication of the annual report and invitation to the ordinary..
25/03GALAPAGOS : Statutory auditor's report on the non-consolidated financial stateme..
25/03GALAPAGOS : Publication of the annual report and invitation to the ordinary shar..
25/03GALAPAGOS : COO Takes On President Role
24/03GALAPAGOS : Names Bart Filius President & COO
24/03Galapagos Appoints Bart Filius as President and Chief Operating Officer
24/03Galapagos appoints Bart Filius as President and Chief Operating Officer
22/03GALAPAGOS NV(ENXTAM : GLPG) added to AMX Index
19/03GALAPAGOS : increases share capital through subscription right exercises
19/03GALAPAGOS NV(ENXTAM : GLPG) dropped from Amsterdam AEX Index
18/03Oxurion NV Business and Financial Update, FY 2020
10/03GALAPAGOS : vers une sortie de l'AEX
10/03EN DIRECT DES MARCHES† : EDF, Stellantis, Alstom, Rothschild, Voyageurs du Monde..
04/03GALAPAGOS : Says Ongoing Anti-inflammatory Drug Trials Meet Primary Endpoint
04/03GALAPAGOS NV : - Transparency notification received from The Capital Group
04/03GALAPAGOS : REPORTS PRIMARY ENDPOINT FOR THE ONGOING FILGOTINIB MANTA AND MANTA-..
04/03Galapagos Reports Primary Endpoint for the Ongoing Filgotinib MANTA and MANTA..
03/03Transparency notification received from The Capital Group
22/02AVIS D'ANALYSTES DU JOUR : Kering, Hermès, Logitech, Air France, Varta, GTT, Ato..
22/02GALAPAGOS : Slumps to FY20 Loss Amid Increased R&D Costs
19/02GALAPAGOS : Shares Rise After FY20 Results Top Expectations
19/02GALAPAGOS NV : - Pipeline and capital for growth
1  2  3  4  5  6  7  8  9  10Volgende
Volgende evenement op GALAPAGOS NV
05/08/21
Komende gebeurtenissen in de sector